Treatment of chronic cough: P2X3 receptor antagonists and beyond.

Sykes, Dominic L; Zhang, Mengru; Morice, Alyn H

Sykes, Dominic L; Zhang, Mengru; Morice, Alyn H.

Affiliation

Sykes DL; Respiratory Research Group, Hull York Medical School, Hull, United Kingdom.
Zhang M; Respiratory Research Group, Hull York Medical School, Hull, United Kingdom.
Morice AH; Respiratory Research Group, Hull York Medical School, Hull, United Kingdom. Electronic address: a.h.morice@hull.ac.uk.

Pharmacol Ther ; 237: 108166, 2022 09.

Article in En | MEDLINE | ID: mdl-35263649

Subject(s)

Cough; Purinergic P2X Receptor Antagonists; Adenosine Triphosphate; Chronic Disease; Cough/drug therapy; Humans; Purinergic P2X Receptor Antagonists/pharmacology; Purinergic P2X Receptor Antagonists/therapeutic use

Key words

ATP; Cough; Gefapixant; P2X3 receptors; Purinergic receptors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cough / Purinergic P2X Receptor Antagonists Limits: Humans Language: En Journal: Pharmacol Ther Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google